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Background: Therapeutic interchange policies in hospitals are useful in dealing with antimicrobial 
shortages and minimising resistance rates. However, the extent of antimicrobial shortages and 
availability of therapeutic interchange policies is unknown among public sector hospitals in South 
Africa, which is a concern. This study aimed to ascertain the extent of antimicrobial shortages among 
public sector hospitals, the presence of current therapeutic interchange policies and the role of 
pharmacists in the process to guide future practice.  
Methods: A quantitative and descriptive study was conducted with a target population of 403 public 
sector hospitals. Data were collected from hospital pharmacists using an electronic questionnaire 
administered via SurveyMonkeyTM. The main outcome measure was the prevalence of public sector 
hospitals with antimicrobial shortages over the past six months and the prevalence of hospitals with 
therapeutic interchange policies.  
Results: The response rate was 33.5%. Most (83.3%) hospitals had experienced shortages in the 
previous six months. Antimicrobials commonly reported as out of stock included cloxacillin (54.3%), 
benzathine benzylpenicillin (54.2%), erythromycin (39.6%) and ceftriaxone (38.0%). Reasons for 
shortages included pharmaceutical companies with supply constraints (85.3%) and an inefficient 
supply system. Only 42.4% had therapeutic interchange policies, and 88.9% contacted the prescriber 
when there was a need for substitution.  
Conclusions: Antimicrobial shortages are prevalent in South African public sector hospitals with 
penicillins and cephalosporins being the most affected. Therapeutic interchange policies are not 
available at most hospitals. Effective strategies are required to improve communication between 
pharmacists and prescribers to ensure safe, appropriate and therapeutically equivalent alternatives 
are available. 
